1A Patients In States With Abortion Bans Might Lose Remote Access To Mifepristone
May 7, 2026
Dr. Colleen Denny, an OB-GYN and medical ethics leader; Dr. Angel Foster, a medication abortion telehealth pioneer; Leah Copeland, a nurse midwife running telehealth operations; and Shefali Luthra, a reproductive health reporter, discuss recent legal fights over remote mifepristone access. They cover how the court rulings could reshape telehealth prescribing, impacts on miscarriage care and rural patients, and operational and legal fallout for providers.
AI Snips
Chapters
Transcript
Episode notes
Mifepristone Regimen Has High Efficacy And Safety
- The mifepristone plus misoprostol regimen yields about 98% complete abortion rates with robust safety evidence across settings.
- This efficacy holds for in-person, synchronous telemedicine, and asynchronous services worldwide.
Mifepristone Is Important For Miscarriage And Stillbirth Care
- Mifepristone is standard care beyond abortion: it's used for retained tissue after miscarriage and to ease stillbirth labor, improving outcomes.
- Losing access would worsen care, increase surgeries, bleeding, and emotional trauma.
Listener Story About Mifepristone After Miscarriage
- A caller described her daughter's 2022 miscarriage managed at home with mifepristone, avoiding a surgical D&C and hospital stay.
- She contrasted this with her own traumatic D&C 44 years earlier, highlighting reduced emotional and financial burden.